Observational studyFrontiers in cellular and infection microbiology2025
Non-invasive monitoring of
Observational study in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06379568 (Risk of Aspergillus Infection in Patients With Chronic Structural Lung Disease), which is not on this map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Risk of Aspergillus Infection in Patients With Chronic Structural Lung Disease
Who cites it
3 citing papers in PubMed.
- Clinical research advances in pulmonary infections in 2025: a narrative review of multipathogen assessment, precision diagnosis, and integrated management.Journal of thoracic disease · 2026Review
- Aspergillosis: An Update on Epidemiology, Risk Factors, Diagnosis, Susceptibility, and Treatment.Journal of fungi (Basel, Switzerland) · 2026Review
- Invasive Pulmonary Aspergillosis in Non-Neutropenic Patients: An Evolving Clinical Paradigm.Diagnostics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diagnosing Methods: This retrospective study included patients with chronic pulmonary diseases from regional centers who experienced acute exacerbations that did not respond to antibacterial therapy, had positive sputum cultures for Results: Of the 2,731 patients assessed, 209 met the study criteria: 112 were identified with Conclusion: This study supports the use of a non-invasive diagnostic approach, combining serological testing and HRCT imaging, to identify patients with chronic lung diseases who have positive sputum cultures for Clinical trial registration: https://www.clinicaltrials.gov, identifier NCT06379568.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.